Our Product Areas
Learn More>
Product Finder
>
Complete product list
>
Product Pipeline
We produce a range of life-saving products that enable many thousands of people around the world to lead normal healthy lives.
In Australia, bioCSL manufactures and in-licenses, markets and distributes vaccines with particular focus on vaccines for the prevention and treatment of serious disease.
CSL Behring Australia supports all aspects of the process from the collection and testing of donated plasma through to the production of a range of plasma-derived products. CSL Behring is the chosen national fractionator of Australia, New Zealand, Hong Kong, Malaysia, Singapore and Taiwan.
Visit our
Product Finder to view the range of products in the following areas:
Plasma-derived therapies >
Vaccines >
Antivenoms >
Diagnostics products >
Pharmaceuticals >
Overview of CSL Behring's product areas
Plasma-derived Therapies:
Used to treat bleeding disorders, infections and autoimmune diseases. Also used to treat patients in critical care settings.
Just as our products vary from country to country, so does the information we can lawfully provide. Overview of bioCSL's product areas
Vaccines:
Used to induce immunity to protect people against a range of viral and bacterial diseases.
Antivenoms:
Used to treat victims of venomous snake and spider bites.
Diagnostics Products:
Used to determine compatibility of donor-recipient blood in transfusion settings.
Pharmaceuticals:
Used to treat a range of human medical conditions. Some products are marketed and distributed by CSL under license from other companies.
Just as our products vary from country to country, so does the information we can lawfully provide.